Exact Sciences Corporatio... (EXAS)
NASDAQ: EXAS
· Real-Time Price · USD
45.59
0.60 (1.33%)
At close: Aug 15, 2025, 3:59 PM
45.68
0.19%
After-hours: Aug 15, 2025, 07:16 PM EDT
Exact Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -140.64M | -155.26M | -164.27M | -214.04M | -175.01M | -240.23M | -204.15M | -282.13M | -431.68M | -516.72M | -623.51M | -716.37M | -734.55M | -745.4M | -595.63M | -811.82M | -864.77M | -774M |
Depreciation & Amortization | 217.26M | 214.98M | 214.86M | 215.88M | 213.37M | 210.81M | 206.61M | 201.92M | 198.23M | 199.65M | 197.56M | 193.2M | 190.83M | 184.29M | 180.35M | 175.04M | 171.98M | 167.72M |
Stock-Based Compensation | 208.33M | 209.1M | 214.88M | 224.26M | 237.43M | 242.58M | 231.32M | 218.66M | 206.26M | 203.49M | 206.79M | 216.76M | 230.86M | 228.21M | 253.06M | 239.01M | 216.88M | 200.64M |
Other Working Capital | 29.6M | 45.4M | -13.1M | -9.16M | -14.13M | -27.31M | -31.99M | 66.24M | 65.22M | 59.46M | 67.21M | -130.72M | -143.2M | -141.17M | -130.25M | -11.53M | 52K | 54.04M |
Other Non-Cash Items | -22.36M | 131.25M | 120.05M | 155.92M | 61.46M | 5.87M | -14.65M | 23.35M | 122.2M | 41.47M | 33.84M | 20.88M | 23.59M | 73.31M | 202.04M | 636.7M | 832.79M | 802.46M |
Deferred Income Tax | -1.41M | -977K | 1.83M | 1.15M | 598K | -419K | -955K | -2.83M | -6.29M | -8.73M | -11.9M | -13.8M | -13.6M | -11.95M | -253.17M | -250.6M | -251.15M | -251.07M |
Change in Working Capital | 44.43M | 73.67M | -34.54M | -7.88M | -76.88M | -51.71M | -342K | 41.36M | 46.25M | -7.22M | -26.38M | -872K | 2.85M | 72.77M | 111.11M | 45.42M | 50.55M | -36.66M |
Operating Cash Flow | 305.61M | 323.66M | 210.54M | 233.02M | 118.66M | 112.02M | 156.12M | 138.61M | 73.32M | -88.02M | -223.56M | -300.17M | -300.02M | -198.76M | -102.24M | 33.74M | 156.29M | 109.08M |
Capital Expenditures | -135.99M | -129.51M | -135.99M | -134.59M | -133.62M | -132.48M | -124.19M | -162.14M | -181.59M | -210.2M | -214.46M | -200.98M | -195.21M | -156.47M | -135.77M | -92.94M | -68.4M | -64.59M |
Cash Acquisitions | -44.76M | -44.76M | -45M | -66.98M | -63.04M | -68.77M | -68.98M | -78.36M | -37.7M | -56.78M | -57.51M | -114.81M | -118.21M | -165.7M | -517.77M | -434.44M | -441.5M | -369.05M |
Purchase of Investments | -175.93M | -309.29M | -406.3M | -471.06M | -414.14M | -308.59M | -139.85M | -104.14M | -103.03M | -69.81M | -131.49M | -244.93M | -327.87M | -1.07B | -1.16B | -1.22B | -1.37B | -827.28M |
Sales Maturities Of Investments | 401.01M | 184.5M | 150.92M | 205.81M | 192.46M | 305.6M | 382.95M | 403.69M | 454.59M | 423.77M | 453.07M | 746.93M | 738.25M | 708.66M | 794.32M | 751.6M | 943.57M | 1.08B |
Other Investing Acitivies | 22.54M | -117.34M | -117.04M | -110.99M | -110.72M | 45K | 112.55M | 111.55M | 136.3M | 136.76M | 24.45M | 24.45M | -10.92M | -44.06M | -69.19M | -480.25M | -469.6M | -436.61M |
Investing Cash Flow | 66.87M | -305.15M | -442.15M | -467.05M | -418.3M | -204.7M | 49.68M | 58.29M | 156.26M | 111.45M | 74.07M | 210.66M | 96.41M | -719.01M | -1.08B | -1.47B | -1.4B | -613.7M |
Debt Repayment | -249.17M | -32.42M | 216.75M | 216.75M | 216.75M | n/a | 137.98M | 137.98M | 137.98M | 187.98M | 50M | 50M | 50M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 36.8M | 19.4M | 19.4M | 47.75M | 26.98M | 28.34M | 28.34M | 9.96M | 9.96M | 25.49M | 25.49M | 38.6M | 38.6M | 23.07M | 23.07M | 18.36M | 18.36M | 18.36M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.41M | -25.41M | -25.41M | -25.41M | -986.55M | -986.55M | -986.55M |
Other Financial Acitivies | -266.44M | -238.04M | 15.12M | 14.66M | 14.98M | 23.17M | 21.79M | 21.86M | 22M | 19.37M | 26.48M | -7.91M | -8.06M | -8.13M | -3.63M | 900.53M | 904.6M | 907.39M |
Financial Cash Flow | -250.41M | -21.3M | 231.87M | 231.41M | 231.73M | 23.17M | 159.77M | 159.83M | 159.97M | 207.35M | 76.48M | 54.19M | 54.03M | 3.96M | 8.47M | 900.53M | 904.6M | 907.39M |
Net Cash Flow | 121.08M | -6.2M | -4.58M | -1.78M | -70.18M | -69.88M | 366.88M | 359.31M | 390.94M | 231.59M | -72.98M | -38.47M | -150.29M | -914.03M | -1.18B | -532.89M | -340.2M | 402.77M |
Free Cash Flow | 169.62M | 194.14M | 74.55M | 98.43M | -14.96M | -20.46M | 31.93M | -23.54M | -108.27M | -298.22M | -438.02M | -501.15M | -495.23M | -355.23M | -238M | -59.2M | 87.89M | 44.49M |